Suzhou Highfine Biotech Co., Ltd.

¥53.94As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301393Healthcare
Country China
PE (Fwd) •••
TSR 3Y CAGR (13.13%)
Div yield 0.75%
ROE 4.93%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.72
PE TTM 46.93
TSR TTM (4.72%)
Mkt cap ¥5.781B
ROIC 6.91%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥60
11.68%
(96.14%)
Hold 2|5|10|12|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.25
1.22
1.34
1.49
22.42%
12.34%
26.67%
33.35%
Revenue¥M
408.2
417.0
426.2
417.2
5.02%
4.00%
4.05%
(0.22%)
Peers (US$866.6M)
Cap (US$)
PE
867.0M
41.80x
864.4M
29.67x
872.1M
978.4x
Capital
TTM
5Y
10Y
Leveragex
1.396
0.029
0.022
EBIT/Intx
3.602
0.114
0.125
Own earn%
(135.64)
(11.89)
(6.45)
Sh yield%
27.09
34.37
30.03
Owners
Insiders/Inst%
1.34
60.42
Short interest%
1.19
SBC / revenue%
5.67
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
0–3
$1 testx
0.0
Incr. ROIC%
2